ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,235 | -51.3% | 163 | -46.2% | 0.00% | – |
Q1 2023 | $8,702 | -3.0% | 303 | 0.0% | 0.00% | – |
Q4 2022 | $8,969 | -84.3% | 303 | -87.3% | 0.00% | – |
Q3 2022 | $57,000 | +338.5% | 2,389 | +315.5% | 0.00% | – |
Q2 2022 | $13,000 | +160.0% | 575 | +187.5% | 0.00% | – |
Q1 2022 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | -50.0% | 200 | -34.9% | 0.00% | – |
Q3 2021 | $14,000 | -79.7% | 307 | -80.6% | 0.00% | – |
Q2 2021 | $69,000 | +27.8% | 1,585 | +18.7% | 0.00% | – |
Q1 2021 | $54,000 | +500.0% | 1,335 | +567.5% | 0.00% | – |
Q4 2020 | $9,000 | -73.5% | 200 | -79.2% | 0.00% | – |
Q3 2020 | $34,000 | -8.1% | 960 | 0.0% | 0.00% | – |
Q2 2020 | $37,000 | +32.1% | 960 | 0.0% | 0.00% | – |
Q1 2020 | $28,000 | -45.1% | 960 | -3.7% | 0.00% | – |
Q4 2019 | $51,000 | -3.8% | 997 | +3.9% | 0.00% | – |
Q3 2019 | $53,000 | +23.3% | 960 | -9.4% | 0.00% | – |
Q2 2019 | $43,000 | +34.4% | 1,060 | 0.0% | 0.00% | – |
Q1 2019 | $32,000 | -11.1% | 1,060 | 0.0% | 0.00% | – |
Q4 2018 | $36,000 | -23.4% | 1,060 | -4.8% | 0.00% | – |
Q3 2018 | $47,000 | +30.6% | 1,114 | +0.5% | 0.00% | – |
Q2 2018 | $36,000 | -32.1% | 1,108 | +4.5% | 0.00% | – |
Q1 2018 | $53,000 | -7.0% | 1,060 | 0.0% | 0.00% | – |
Q4 2017 | $57,000 | -8.1% | 1,060 | 0.0% | 0.00% | – |
Q3 2017 | $62,000 | +19.2% | 1,060 | 0.0% | 0.00% | – |
Q2 2017 | $52,000 | +13.0% | 1,060 | 0.0% | 0.00% | – |
Q1 2017 | $46,000 | +9.5% | 1,060 | +23.3% | 0.00% | – |
Q4 2016 | $42,000 | -4.5% | 860 | -6.9% | 0.00% | – |
Q3 2016 | $44,000 | -4.3% | 924 | +7.4% | 0.00% | – |
Q2 2016 | $46,000 | +12.2% | 860 | -6.5% | 0.00% | – |
Q1 2016 | $41,000 | +17.1% | 920 | 0.0% | 0.00% | – |
Q4 2015 | $35,000 | +20.7% | 920 | 0.0% | 0.00% | – |
Q3 2015 | $29,000 | -52.5% | 920 | -50.5% | 0.00% | – |
Q2 2015 | $61,000 | +8.9% | 1,859 | +37.8% | 0.00% | – |
Q1 2015 | $56,000 | -6.7% | 1,349 | -9.1% | 0.00% | – |
Q4 2014 | $60,000 | +9.1% | 1,484 | 0.0% | 0.00% | – |
Q3 2014 | $55,000 | +27.9% | 1,484 | +61.3% | 0.00% | – |
Q2 2014 | $43,000 | – | 920 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |